SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/18/20 Thermo Fisher Scientific Inc. SC TO-T/A 16:7.0M Qiagen N.V. Toppan Merrill/FA Quebec B.V. |
Document/Exhibit Description Pages Size 1: SC TO-T/A Amendment to Tender-Offer Statement by a Third HTML 88K Party 2: EX-99.(A)(1)(A) Miscellaneous Exhibit HTML 1.50M 3: EX-99.(A)(1)(B) Exhibit (A)(1)(B) HTML 119K 4: EX-99.(A)(1)(C) Exhibit (A)(1)(C) HTML 29K 5: EX-99.(A)(1)(D) Exhibit (A)(1)(D) HTML 39K 6: EX-99.(A)(1)(E) Exhibit (A)(1)(E) HTML 51K 7: EX-99.(A)(1)(F) Exhibit (A)(1)(F) HTML 62K 8: EX-99.(A)(1)(G) Exhibit (A)(1)(G) HTML 55K 11: EX-99.(D)(2) Exhibit (D)(2) HTML 35K 12: EX-99.(D)(3) Exhibit (D)(3) HTML 28K 13: EX-99.(D)(4) Exhibit (D)(4) HTML 28K 14: EX-99.(D)(5) Exhibit (D)(5) HTML 28K 15: EX-99.(D)(6) Exhibit (D)(6) HTML 30K 16: EX-99.(D)(7) Exhibit (D)(7) HTML 37K 9: EX-99.A5G Miscellaneous Exhibit HTML 25K 10: EX-99.A5H Miscellaneous Exhibit HTML 14K
tm2016683-5_sctota_DIV_111-ex99d2 - none - 1.2783694s |
| | | | | |
Current
|
| | |
Proposed
|
| |
| |
Salary
|
| | |
$500K
|
| | |
$512K
(including rollover of car allowance and deferred compensation contribution) |
| |
| |
Target Bonus
|
| | |
100% of base salary
|
| | |
100% of base salary
|
| |
| |
Target Total Cash
|
| | |
$1.0 M
|
| | |
$1.042 M
|
| |
| |
Long-Term Incentive Award
|
| | |
2020 Annual Grant: ~$5.2 M
2019 Annual Grant: ~$2.1 M October 31, 2018 Commitment PSU Grant: 50,000 units (~$1.8 M @ $36.30 closing price) 2018 Annual Grant: ~$1.6 M |
| | |
$2 M Founders Grant shortly after Closing
50% Options / 50% time-based restricted stock units (“Time RSUs”) $1.0 M Annual Grant in 2022 and ongoing Standard Band 13 Mix Commitment PSU program will discontinue |
| |
| | Total Direct Comp (ongoing) | | | | | | | |
$2.042 M
|
| |
| | Other Benefits: | | | ||||||||
| |
Synergy Bonus
|
| | | | | | |
Up to $521K Maximum
(l x Target Bonus) Payable based on 2021 (33%) and 2022 (67%) performance |
| |
| |
Interim CEO Bonus
|
| | |
$50,000 monthly beginning January 2020 through the duration of CEO role
|
| | |
Will Discontinue at Closing
|
| |
| | Company Car Allowance | | | |
$1,500 monthly / $18,000 annually
|
| | |
Will Discontinue at Closing
|
| |
| |
401(k) Match / DCP
|
| | |
$24,000 contribution to Deferred Compensation Account
|
| | |
100% of 6% of contributed
Salary + Bonus (lump sum contribution discontinues) |
| |
| |
Severance
|
| | |
Salary and benefit continuation for earlier of 12 months or effective date of reemployment
|
| | |
Executive Severance Policy benefit of 12 months’ salary, target bonus and benefits
|
| |
| |
Change-In-Control
|
| | |
Lump sum payment of
12 months’ salary / bonus |
| | |
18 months’ salary / bonus plus
24 months’ benefits; prorated bonus for period worked |
| |
| |
Supplemental LTD
|
| | | | | | |
Up to $10K / month additional
($22K / month total) |
| |
| | Supplemental Life Insurance | | | | | | | |
Level of coverage: 3x Base
($2 M Maximum) |
| |
| |
Other Benefits
|
| | | | | | |
Executive wellness and financial planning benefits
|
| |
This ‘SC TO-T/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 5/18/20 | |||
3/2/20 | 20-F, 4, IRANNOTICE | |||
1/1/20 | ||||
10/31/18 | 6-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/13/20 Thermo Fisher Scientific Inc. SC TO-T/A 3:143K Qiagen N.V. Toppan Merrill/FA 8/11/20 Thermo Fisher Scientific Inc. SC TO-T/A 2:126K Qiagen N.V. Toppan Merrill/FA 8/10/20 Thermo Fisher Scientific Inc. SC TO-T/A 2:121K Qiagen N.V. Toppan Merrill/FA 8/07/20 Thermo Fisher Scientific Inc. SC TO-T/A 2:119K Qiagen N.V. Toppan Merrill/FA 8/06/20 Thermo Fisher Scientific Inc. SC TO-T/A 2:118K Qiagen N.V. Toppan Merrill/FA 8/05/20 Thermo Fisher Scientific Inc. SC TO-T/A 2:116K Qiagen N.V. Toppan Merrill/FA 8/04/20 Thermo Fisher Scientific Inc. SC TO-T/A 3:133K Qiagen N.V. Toppan Merrill/FA 8/03/20 Thermo Fisher Scientific Inc. SC TO-T/A 2:112K Qiagen N.V. Toppan Merrill/FA |